Taxane-based chemotherapy

Phase 3Small molecule

Roche

Taxane-based chemotherapy is one of 48 small molecule programs targeting Breast Cancer. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Breast CancerActive, not recruiting

Metastatic Breast CancerRecruiting

Breast CancerPhase 2

Active, not recruiting

Metastatic Breast CancerPhase 3

Recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Taxane-based chemotherapy

Roche

Phase 3

2 2

Cymbalta

Alnylam Pharmaceuticals

Preclinical

3 3

Adenocard

Astellas

Preclinical

1 4

Zolymbus

AbbVie

Preclinical

1 5

Methylthioninium Chloride

PProvepharm SAS

Preclinical

3 6

Spravato

WWim Janssens

Preclinical

2 7

Sporanox

SSebela Pharmaceuticals Development LLC

Preclinical

1 8

Neoadjuvant Therapy

SSun Yat-sen University

Preclinical

3 9

Gadolinium-Chelate

MM.D. Anderson Cancer Center

Preclinical

1 10

Escitalopram Oxalate

TTorrent Pharmaceuticals Limited

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2032

Phase 3Recruiting

Metastatic Breast Cancer

NCT05894239

Clinical

Trials by Indication[1]

Breast Cancer2 trials

A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.

Completed· Roche logo

Roche·Phase 3·NCT00448591·2,296 enrolled

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

Withdrawn·JJenny C. Chang, MD·Phase 2·NCT02067416

Metastatic Breast Cancer1 trial

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo As Maintenance Therapy After First Line Induction Therapy in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Recruiting· Roche logo

Roche·Phase 3·NCT05894239·230 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Taxane-based chemotherapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Taxane-based chemotherapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Taxane-based chemotherapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Roche company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Roche

Taxane-based chemotherapy

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2032

Trials by Indication[1]

Breast Cancer2 trials

Metastatic Breast Cancer1 trial

References

Drug Info

Quick Facts

Related News